Skip to content

Opening book details…

About this Medicine article

Updated Overall Survival (Os) from the Phase 3 Trial, Ca184-043: Ipilimumab (Ipi) Vs Placebo (Pbo) in Patients with Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer (Mcrpc) by Fizazi, K. ;Drake, C.G. ;Kwon, E.D. ;Bossi, A. ;van den Eertwegh, A.J. ;Scher, H.I. ;Beer, T.M. ;McHenry, M.B. ;Liu, D. ;Gerritsen, W.R. ;Logothetis, C. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Fizazi, K. ;Drake, C.G. ;Kwon, E.D. ;Bossi, A. ;van den Eertwegh, A.J. ;Scher, H.I. ;Beer, T.M. ;McHenry, M.B. ;Liu, D. ;Gerritsen, W.R. ;Logothetis, C.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2014
Language
EN
Field
Medicine (Health Sciences)

More by Fizazi, K. ;Drake, C.G. ;Kwon, E.D. ;Bossi, A. ;van den Eertwegh, A.J. ;Scher, H.I. ;Beer, T.M. ;McHenry, M.B. ;Liu, D. ;Gerritsen, W.R. ;Logothetis, C.

Browse all works by Fizazi, K. ;Drake, C.G. ;Kwon, E.D. ;Bossi, A. ;van den Eertwegh, A.J. ;Scher, H.I. ;Beer, T.M. ;McHenry, M.B. ;Liu, D. ;Gerritsen, W.R. ;Logothetis, C.